Amount Raised
$16.5 Million
Round Type
Post-IPO Equity
RichmondBiotechnologyHealth CareGeneticsTherapeuticsInvestors
Description
Sangamo Therapeutics, Inc. has entered into an underwriting agreement for an offering of common stock and pre-funded warrants. The offering consists of over 35 million shares of common stock and accompanying warrants. The combined offering price per share is set at approximately $0.4719, aiming to generate essential funds for the company's ongoing projects.
Who to call at Sangamo Therapeutics, and when
A new round usually means Sangamo Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Sangamo Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Sangamo Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Sangamo Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Sangamo Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Sangamo Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.